Loading provider…
Loading provider…
Dermatology Physician in Orange, CA
NPI: 1356390181Primary Practice Location
UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER
101 The City Dr S, Orange, CA
Primary Employer
UCI Department of Dermatology
ucihealth.org
HQ Phone
Get MD, PHD, DSCI Sergei's Phone NumberMobile
Get MD, PHD, DSCI Sergei's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1996 - 2026
MN State Medical License
1996 - 1997

American Board of Dermatology
Dermatology
University of California Davis Health
Residency • Dermatology
1996 - 1999
National Medical University Kiev
Medical School
Until 1980
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 147 | 255 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 114 | 138 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 86 | 276 |
| 4 | 17000Destruction of skin growth | 66 | 87 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 55 | 89 |
Authors: Grando, S A, Drannik, G N
Journal: Biull Eksp Biol Med
The ultrastructural changes in the clinically unaffected skin of patients with pemphigus vulgaris
Authors: Sergei A. Grando, Glukhen'kiĭ Bt, A.S. Stupina, A.K. Terman
Publication Date: 1990-01
[Effect of enterosorption on the microcirculation and the clinical picture in pruritic dermatoses].
Authors: Grando, S A, Glukhen'kaia, A B, Ivanchenko, L L, Amalian, V A
Journal: Vestn Dermatol Venerol
Lead Sponsor: University of California, Irvine
Collaborators: Grifols Therapeutics LLC
Intervention / Treatment: DRUG: IVIg
Lead Sponsor: University of California, Irvine
Intervention / Treatment: DRUG: Sirolimus (formerly known as Rapamycin)